851520--2/24/2010--EXPONENT_INC

related topics
{regulation, government, change}
{stock, price, share}
{system, service, information}
{stock, price, operating}
{interest, director, officer}
{personnel, key, retain}
{customer, product, revenue}
{financial, litigation, operation}
{condition, economic, financial}
{competitive, industry, competition}
{loan, real, estate}
Lack of sizable backlog may lead to less predictable, and perhaps lower, future revenues. Failure to attract and retain key employees may adversely affect our business. Competition could reduce our pricing and adversely affect our business. The loss of a large client could adversely affect our business. Our business can be adversely affected by downturns in the overall economy. Our clients may be unable to pay for our services. We hold substantial investments that could present liquidity risks. Our business is dependent on our professional reputation. Our business can be adversely impacted by deregulation or reduced regulatory enforcement. Tort reform can reduce demand for our services. Our quarterly results may vary. Our engagements may result in professional or other liability. Potential conflicts of interests may preclude us from accepting some engagements. We hold substantial investments that could present liquidity risks. Our business is dependent on our professional reputation. Our business can be adversely impacted by deregulation or reduced regulatory enforcement. Tort reform can reduce demand for our services. Our quarterly results may vary. Our engagements may result in professional or other liability. Potential conflicts of interests may preclude us from accepting some engagements. We may not be successful in obtaining approval from our shareholders to increase the number of common shares issuable under our equity incentive plans. The market price of our common stock may be volatile. We may not be successful in obtaining approval from our shareholders to increase the number of common shares issuable under our equity incentive plans. The market price of our common stock may be volatile.

Full 10-K form ▸

related documents
737561--2/2/2010--UCI_MEDICAL_AFFILIATES_INC
737561--4/8/2010--UCI_MEDICAL_AFFILIATES_INC
1013556--4/17/2007--COMMODORE_APPLIED_TECHNOLOGIES_INC
857728--3/3/2006--I_FLOW_CORP_/DE/
890908--11/21/2006--DYNACQ_HEALTHCARE_INC
907471--1/11/2008--META_FINANCIAL_GROUP_INC
96057--10/4/2006--SYS
1017813--5/9/2008--CAREGUIDE_INC
907471--12/12/2008--META_FINANCIAL_GROUP_INC
822418--3/5/2009--BIO_IMAGING_TECHNOLOGIES_INC
1293243--3/14/2007--PRA_International
822418--3/5/2008--BIO_IMAGING_TECHNOLOGIES_INC
822418--3/29/2007--BIO_IMAGING_TECHNOLOGIES_INC
12239--4/2/2007--SPHERIX_INC
777491--2/25/2010--CH2M_HILL_COMPANIES_LTD
777491--2/29/2008--CH2M_HILL_COMPANIES_LTD
777491--2/24/2009--CH2M_HILL_COMPANIES_LTD
1080757--3/31/2009--VIRTUAL_EDUCATION_SOFTWARE_INC
2186--3/14/2006--RELM_WIRELESS_CORP
2186--3/7/2007--RELM_WIRELESS_CORP
2186--3/5/2008--RELM_WIRELESS_CORP
857728--3/30/2007--I_FLOW_CORP_/DE/
1110189--3/22/2006--I_TRAX_INC
777491--2/23/2007--CH2M_HILL_COMPANIES_LTD
75439--3/31/2009--CytoCore_Inc
28452--4/17/2007--DEVCON_INTERNATIONAL_CORP
1196501--3/9/2007--HMS_HOLDINGS_CORP
857728--3/17/2008--I_FLOW_CORP_/DE/
1063980--2/27/2006--CLARK_INC
1196501--3/11/2009--HMS_HOLDINGS_CORP